T-Cell Immunotherapy Market (2nd Edition), 2017-2030PR Newswire (press release)More specifically, T-cell immunotherapies are classified into three major segments, namely chimeric antigen receptor (CAR) T-cell, T-cell receptor (TCR) and tumor infiltrati… Continue reading
Thorold News |
Maxim bullish on Abeona, sees 89% upside on prospects of lead gene therapy candidate EB-101; shares up 2%
Seeking Alpha Maxim Group ups its fair value target for Abeona Therapeutics (ABEO +2.2%) to $17 (89% upside) from $14 citing positive prospects for its lead gene therapy candidate, Orphan Drug-tagged EB-101, for the treatment of recessive dystrophic epidermolysis … Maxim Group Just Issued “Buy” Rating on Abeona Therapeutics Inc (ABEO)Highland Mirror Analysts are on the Bearish side about Abeona Therapeutics Inc (NASDAQ:ABEO) this week.WeeklyHub |
|
Oppenheimer Starts Coverage on Editas Medicine, Inc. (EDIT) By Announcing An Initial Rating Of “Perform”
Highlight Press CRISPR uses a protein-ribonucleic acid (RNA) complex composed of an enzyme, including either Cas9 (CRISPR associated protein 9) or Cpf1 (CRISPR from Prevotella and Francisella 1), bound to a guide RNA molecule designed to recognize a particular … |
|
Oppenheimer Starts Coverage on Editas Medicine, Inc. (EDIT) By Announcing An Initial Rating Of “Perform”
Highlight Press CRISPR uses a protein-ribonucleic acid (RNA) complex composed of an enzyme, including either Cas9 (CRISPR associated protein 9) or Cpf1 (CRISPR from Prevotella and Francisella 1), bound to a guide RNA molecule designed to recognize a particular … |
|
New Gene Therapy Routes for Motor Disease Uncovered in New Study
Drug Discovery & Development Scientists investigating the genetic causes and altered functioning of nerve cells in motor neurone disease (MND) have discovered a new mechanism that could lead to fresh treatment approaches for one of the most common forms of the disease. The team … |
NormanObserver.com |
Oppenheimer Starts Coverage on Editas Medicine, Inc. (EDIT) By Announcing An Initial Rating Of “Perform”
Highlight Press CRISPR uses a protein-ribonucleic acid (RNA) complex composed of an enzyme, including either Cas9 (CRISPR associated protein 9) or Cpf1 (CRISPR from Prevotella and Francisella 1), bound to a guide RNA molecule designed to recognize a particular … Oppenheimer Begins Coverage on Editas Medicine, Inc. (EDIT) With …First News 24 |